Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 3, 119
- https://doi.org/10.3389/fphar.2012.00119
Abstract
Atherosclerosis is an inflammatory process of the vascular wall characterized by the infiltration of lipids and inflammatory cells. Oxidative modifications of infiltrating low-density lipoproteins and induction of oxidative stress play a major role in lipid retention in the vascular wall, uptake by macrophages and generation of foam cells, a hallmark of this disorder. The vasculature has a plethora of protective resources against oxidation and inflammation, many of them regulated by the Nrf2 transcription factor. Heme oxygenase-1 (HO-1) is a Nrf2-regulated gene that plays a critical role in the prevention of vascular inflammation. It is the inducible isoform of HO, responsible for the oxidative cleavage of heme groups leading to the generation of biliverdin, carbon monoxide, and release of ferrous iron. HO-1 has important antioxidant, antiinflammatory, antiapoptotic, antiproliferative, and immunomodulatory effects in vascular cells, most of which play a significant role in the protection against atherogenesis. HO-1 may also be an important feature in macrophage differentiation and polarization to certain subtypes. The biological effects of HO-1 are largely attributable to its enzymatic activity, which can be conceived as a system with three arms of action, corresponding to its three enzymatic byproducts. HO-1 mediated vascular protection may be due to a combination of systemic and vascular local effects. It is usually expressed at low levels but can be highly upregulated in the presence of several proatherogenic stimuli. The HO-1 system is amenable for use in the development of new therapies, some of them currently under experimental and clinical trials. Interestingly, in contrast to the HO-1 antiatherogenic actions, the expression of its transcriptional regulator Nrf2 leads to proatherogenic effects instead. This suggests that a potential intervention on HO-1 or its byproducts may need to take into account any potential alteration in the status of Nrf2 activation. This article reviews the available evidence that supports the antiatherogenic role of HO-1 as well as the potential pathways and mechanisms mediating vascular protection.This publication has 139 references indexed in Scilit:
- Heme Oxygenase-1 Contributes to an Alternative Macrophage Activation Profile Induced by Apoptotic Cell SupernatantsMolecular Biology of the Cell, 2009
- Heme oxygenase-1: from biology to therapeutic potentialTrends in Molecular Medicine, 2009
- Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in MicePLOS ONE, 2008
- Pharmacological and Clinical Aspects of Heme OxygenasePharmacological Reviews, 2008
- Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cellsGenome Biology, 2007
- Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic EffectsThe Journal of pharmacology and experimental therapeutics, 2006
- Biliverdin therapy protects rat livers from ischemia and reperfusion injuryHepatology, 2004
- Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patientsHuman Genetics, 2002
- Association of smoking and low serum bilirubin antioxidant concentrationsAtherosclerosis, 1998
- Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996